Brief: Galera Therapeutics Receives Letter From Nasdaq Indicating That Co Has Not Regained Compliance With Listing Rules
27/03/2024 11:43
March 27 (Reuters) - Galera Therapeutics Inc GRTX.O :
* GALERA THERAPEUTICS - ON MARCH 26 RECEIVED LETTER FROM
NASDAQ
STAFF INDICATING THAT CO HAS NOT REGAINED COMPLIANCE WITH MVPHS
* GALERA THERAPEUTICS - INTENDS TO REQUEST HEARING BEFORE A
PANEL
AT WHICH IT WILL REQUEST CONTINUED LISTING PENDING ITS RETURN TO
COMPLIANCE
Source text for Eikon: ID:n0001193125-24-078226
Further company coverage: GRTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Galera Therapeutics
See all newsBrief: Galera Therapeutics Says Nasdaq Will Delist Co's Common Stock By Filing Form 25 With SEC On Sept 4
Brief: Galera Announces Board Approval Of Complete Liquidation And Dissolution
Brief: Galera Therapeutics Receives Written Notice From Nasdaq Indicating That Nasdaq Hearings Panel Determined To Delist Co’s Shares
Brief: Alpha Pharma Investments Llc Reports 10.899% Passive Stake In Galera Therapeutics
Brief: Galera Adopts Limited Duration Stockholder Rights Agreement